Nano-Targeting of Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 4
Special Issue Editor
Interests: artificial cells; biomaterials; blood substitutes; drug delivery; nanobiotherapeutic; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue on “Nano-Targeting of Cancer”.
Nano-targeting technology is important in cancer therapy. However, the aim of cancer therapy is not just to suppress cancer growth. It also includes the management of side effects caused by cancer itself and those resulting from cancer therapy. Additionally, it involves the management of other aspects of cancer treatment, including improving drug delivery precision and minimizing harm to healthy tissues. One potential area to explore for optimal cancer therapy is the development of advanced nano-targeting systems for the delivery of drugs, prodrugs, mRNA, genomes, biotherapeutic agents, and immunotherapeutic agents, among others. This includes their ability to deliver therapeutic agents to the microenvironment or even intracellularly of cancer cells, enhancing treatment effectiveness while reducing toxicity.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: nano-targeting in cancer therapy from the basic concepts, design, and development of nano-targeting systems, feasibility studies, and application of nanocarriers such as nanocapsules, nanoparticles, liposomes, and nanorobotics, to their use in targeted delivery to suppress cancer growth, minimize side effects, and improve therapeutic outcomes.
The aim of this Special Issue is to provide an opportunity to explore different nano-targeting approaches and the various stages of their development and application in cancer therapy.
We look forward to receiving your contributions.
Prof. Dr. Thomas Ming Swi Chang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- artificial intelligence
- targeted delivery
- nanorobotics
- prodrug activation
- intracellular action
- liposome
- PEGylation
- nanoparticles
- nanocapsules
- nanoartificial cells
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
